Delay of diabetic cataract progression by a chemical chaperone trimethylamine N-oxide through alleviating...

This study aims to investigate the protective effects of trimethylamine N-oxide (TMAO), a natural occurring chaperone, on delaying diabetic cataract (DC) progression. Rats were divided into 4 experimental groups: untreated controls, TMAO treatment only, streptozotocin-induced diabetic mellitus (DM), and DM with TMAO therapy. After 10 weeks, aqueous humor TMAO levels and lens opacity were assessed. Immunofluorescence analyses and Western blotting were utilized to evaluate epithelial-mesenchymal transition (EMT)-related genes in lens epithelial cells (LECs). In vitro, HLE-B3 cells were treated with or without TMAO under high glucose (HG) environment (50 mmol/L), then collected for RNA-seq. Apoptosis and reactive oxygen species (ROS) were evaluated by flow cytometry while endoplasmic reticulum stress (ERS)-related genes were observed by western blotting. Elevated aqueous humor TMAO levels were detected in DC rats, compared to controls. In vivo and ex vivo, TMAO reduced HG-induced lens opacity and EMT in LECs. In vitro experiments demonstrated that HG resulted in enhanced apoptosis, migration, ROS and EMT-related genes in HLE-B3 cells while TMAO addition diminished these effects. RNA-seq revealed that the inhibition of ERS was the key factor to reverse the impacts of HG on LECs by TMAO and mechanistic investigations suggested that ERS-related pathway were significantly inhibited in TMAO treated LECs under HG or tunicamycin-induced ERS. Moreover, TMAO improved the solubility of lens protein in DC rats. Our study pioneered the confirmation of the protective role of TMAO in DC through inhibiting lens protein unfolding, suppressing ERS, and alleviating ERS-induced apoptosis, ROS and EMT in LECs.